Roche targets liver disease treatments with acquisition Deal includes $14.50 a share, potential milestone payments up to $6.00 a share Roche flags potential to treat obesity-related conditions The ...
We recently published 10 Stocks Stole the Show, 5 Hit Historic Highs. 89bio Inc. (NASDAQ:ETNB) is one of the best performers on Thursday. Shares of 89bio surged to a fresh record high on Thursday as ...
Dowling Catholic wide receiver Sam Drexler (1) watches a pass go by just out of reach during a high school football game between Valley and Dowling Catholic on Aug. 29, 2025, at Valley Stadium in West ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback